glp 1 and glp Glucagon-like peptide in health disease PDB-101: Molecule of the Month:

doi: 10.1152/ajplung.00259.2014 319 ProfitaMBonannoAMontalbanoAMAlbanoGDRiccobonoLSienaLet al

(Refer to Table 1 for details of clinical trials evaluating GLP-1 and insulin)

As documented in Supplementary Material 2: Table 1 : The Weight of Evidence (WoE) approach undertaken to evaluate the literature obtained first examined the scope of each paper, describing the study or review undertaken, the range of concentrations/doses tested where given, and collated the uncertainties and limitations of each paper reviewed, to arrive at a summary of the literature for each chemical, in relation to the specific endpoints under scrutiny

Duah notes that rapid weight loss can accelerate bone loss, and without enough vitamin D and calcium, the risk of osteoporosis may increase over time

n.s., not significant (two-tailed Students t -test)

Citicoline improves verbal memory in aging